Christine Mikail Cvijic - 13 Mar 2025 Form 4 Insider Report for Neurogene Inc. (NGNE)

Signature
/s/ Christine Mikail
Issuer symbol
NGNE
Transactions as of
13 Mar 2025
Net transactions value
-$76,247
Form type
4
Filing time
17 Mar 2025, 17:14:56 UTC
Previous filing
25 Nov 2024
Next filing
28 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGNE Common Stock Sale $76,247 -4,501 -5.9% $16.94 72,343 13 Mar 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On March 12, 2024, a Restricted Stock Unit (RSU) held by the Reporting Person vested in part. The shares issuable on vesting of the RSU are reported as shares held by the Reporting Person. The award agreement for the RSU provides that the Registrant shall sell a number of shares necessary to cover the Reporting Person's tax withholding responsibility created by the vesting event, with no election made by the Reporting Person. The sale reported on this Form 4 relates exclusively to this mandatory sale upon vesting of the RSU.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.38 to $17.21, inclusive. The reporting person undertakes to provide to the Registrant, any security holder of the Registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Includes 24,000 shares held jointly by the reporting person and her spouse, David Cvijic.